MATARRESE, MARIO
 Distribuzione geografica
Continente #
AS - Asia 1.209
NA - Nord America 910
EU - Europa 245
SA - Sud America 213
AF - Africa 26
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.610
Nazione #
US - Stati Uniti d'America 878
SG - Singapore 538
CN - Cina 253
BR - Brasile 171
HK - Hong Kong 145
VN - Vietnam 104
FR - Francia 83
IT - Italia 45
KR - Corea 39
JP - Giappone 29
DE - Germania 24
GB - Regno Unito 23
IN - India 22
BD - Bangladesh 21
AR - Argentina 18
NL - Olanda 18
CA - Canada 15
FI - Finlandia 10
EC - Ecuador 8
ID - Indonesia 8
MX - Messico 7
AU - Australia 6
IQ - Iraq 6
PL - Polonia 6
TR - Turchia 6
UZ - Uzbekistan 6
PK - Pakistan 5
SE - Svezia 5
CO - Colombia 4
IL - Israele 4
OM - Oman 4
SA - Arabia Saudita 4
TT - Trinidad e Tobago 4
UA - Ucraina 4
ZA - Sudafrica 4
AL - Albania 3
CL - Cile 3
DZ - Algeria 3
EG - Egitto 3
ES - Italia 3
NP - Nepal 3
SN - Senegal 3
VE - Venezuela 3
AT - Austria 2
BO - Bolivia 2
JO - Giordania 2
KE - Kenya 2
MA - Marocco 2
MY - Malesia 2
NO - Norvegia 2
PY - Paraguay 2
RO - Romania 2
RU - Federazione Russa 2
SC - Seychelles 2
TN - Tunisia 2
UY - Uruguay 2
AZ - Azerbaigian 1
BB - Barbados 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
CH - Svizzera 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GD - Grenada 1
HR - Croazia 1
HU - Ungheria 1
IE - Irlanda 1
IM - Isola di Man 1
IR - Iran 1
JM - Giamaica 1
KN - Saint Kitts e Nevis 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
PS - Palestinian Territory 1
RS - Serbia 1
SI - Slovenia 1
TG - Togo 1
TH - Thailandia 1
TZ - Tanzania 1
ZW - Zimbabwe 1
Totale 2.609
Città #
Santa Clara 496
Singapore 297
Hong Kong 142
Hefei 80
Beijing 71
Lauterbourg 58
Los Angeles 42
San Jose 39
Seoul 39
Ashburn 37
Ho Chi Minh City 35
Hanoi 24
Tokyo 24
Buffalo 14
Guangzhou 13
São Paulo 12
Frankfurt am Main 11
Helsinki 10
New York 10
Dallas 9
Milan 9
Da Nang 8
Falkenstein 8
Chicago 7
Rio de Janeiro 7
Belo Horizonte 6
Guarulhos 6
London 6
Orem 6
Tashkent 6
Amsterdam 5
Atlanta 5
Manchester 5
Stockholm 5
Florence 4
Haiphong 4
Minamishinagawa 4
Montreal 4
Ninh Bình 4
Piscataway 4
Recife 4
Sydney 4
Toronto 4
Warsaw 4
Bengaluru 3
Boston 3
Chennai 3
Council Bluffs 3
Dakar 3
Düsseldorf 3
Fortaleza 3
Houston 3
Hải Dương 3
Johannesburg 3
Maringá 3
Muscat 3
Naples 3
Newark 3
Philadelphia 3
Port of Spain 3
Portsmouth 3
Quito 3
Salvador 3
Shanghai 3
Sorocaba 3
Amman 2
Baghdad 2
Bologna 2
Bragança Paulista 2
Bảo Lộc 2
Cairo 2
Campinas 2
Caracas 2
Castel d'Azzano 2
Caxias do Sul 2
Chongqing 2
Ciudad del Este 2
Contagem 2
Cuiabá 2
Dammam 2
Dhaka 2
Dourados 2
Duque de Caxias 2
El Paso 2
Erechim 2
Guayaquil 2
Hixson 2
Istanbul 2
Kansas City 2
Lahore 2
Las Vegas 2
Marion 2
Marseille 2
Mexico City 2
Minneapolis 2
Montevideo 2
Nairobi 2
Natal 2
Ocala 2
Papillion 2
Totale 1.725
Nome #
Radiosynthesis and quality control of [18F]F-MISO. A radiotracer for detection of cellular hypoxia 80
Development of [methoxy-11C]RN5 as a potential radioligand for the in vivo PET measurement of myocardial alpha1A-adrenoceptors 72
An optimized semiautomatic method for labelling of palmitic acid with ( 11C)CO2 68
Synthesis, labeling, and biological evaluation of halogenated 2 quinolinecarboxamides as potential radioligands for the visualization of peripheral benzodiazepine receptors 62
Microglial activation in Parkinson's disease and Lewy body dementia: A PET study 59
Comparison of several solvents and bases for improving radio-synthesis yield of [11C]PIB ([N-methyl-11C]2-(4'- methylaminophenyl)-6-hydroxybenzothiazole) 57
Glucose metabolism and serotonin receptors in the frontotemporal lobe degeneration 56
Automated production of copper radioisotopes and preparation of high specific activity [(64)Cu]Cu-ATSM for PET studies. 51
Role of TREM-2 in neurodegenerative disorders of the central nervous system 51
Longitudinal evaluation of tissue hypoxia and glucose metabolism in different preclinical models of cancer 50
Synthesis and preliminary evaluation of carbon-11-meta-hydroxyephedrine: a false transmitter agent for the hearth neurological imaging 50
In vivo evaluation of mu-opioid receptors in obesity: a PET study. 49
Evaluation of three quinoline-carboxamide derivatives as potential radioligands for the in vivo pet imaging of neurodegeneration 49
In vivo PET study of 5HT(2A) serotonin and D(2) dopamine dysfunction in drug-naive obsessive-compulsive disorder. 47
Exploring Translocator Protein (TSPO) Medicinal Chemistry: An Approach for Targeting Radionuclides and Boron Atoms to Mitochondria 46
Molecular imaging for the in vivo measurement of microglial activation in Creutzfeldt-Jakob Disease (CJD) 45
Comparison of several solvents and bases to improve radiochemical yield of [11C]PIB: N-methyl[11C]2-(4'- methylaminophenyl) - 6- hydroxybenzothiazole 45
Microglial activation in Parkinson's disease and Lewy Body Dementia: PET studies and proteomic analysis 45
A comparative study of several solvents and bases for radiochemical - yield improvement of [11C]PIB: N-methyl-[11C]-(4'- methylaminophenyl) - 6 hydroxybenzothiazole 44
Monitoring disease evolution and treatment response in lysosomal disorders by the peripheral benzodiazepine receptor ligand PK11195. 43
Autoradiographic and small-animal pet comparisons between [18fFfaza and [64Cu]ATSM in EMT-6, fadu and PC-3 xenograft tumor models 43
In vivo evaluation of mu opioid receptors in obesity: a PET in vivo 43
Synthesis and carbon-11 labeling of (R)- and (S)-thionisoxetine, norepinephrine reuptake inhibitors, potential radioligands for positron emission tomography. 42
Non-peptide NK(1) receptor ligands based on the 4-phenylpyridine moiety. 42
Radiosynthesis and preliminary biological evaluation of [18F]VC701, antagonist of PBR receptor, potentially useful for the study of neurodegenerative diseases 41
MI in Cancer Biology Visualisation of Extra- and Intracellular Processes PET and MRI studies applied on characterization of Fisher/F98 rat glioma model 41
Effect of fluvoxamine on cortical 5HT2A receptors assessed dy PET and (11C) MDL100907 in drug naive obsessive compulsive patients 41
Quinolinic acid induced neurodegeneration in the striatum: a combined in vivo and in vitro analysis of receptor changes and microglia activation. 40
In vitro evaluation of mu-opioid receptors in obesity: a PET study 40
Progression of Parkinson's disease in patients with early and late onset disease: a PET study with [11C]Fe-CIT 40
Synthesis and biological characterization of novel 2-quinolinecarboxamide ligands of the peripheral benzodiazepine receptors bearing technetium-99m or rhenium. 39
Characterization of a rat glioma model with MR, [18F]FAZA- and [18F]FDG-PET imaging 39
Evaluation of three quinoline carboxamide derivatives as potential radioligands for the in vivo PET imaging of neurodegeneration 39
Autoradiographic ans small animal PET comparison between [18F]FAZA and [64Cu]ATSM in EMT-6, FaDu and PC-3 xenograft tumor 38
Dopamine D2 receptors in drug naive obsessive compulsive patients: Effect of fluvoxamine assessed by PET and [11C]Raclopride 37
[11C]RN5: a new agent for the in vivo imaging of myocardial receptors 35
Value of [11C]choline-PET in RE.staging prostate cancer: a comparison with [18F]FDG 35
Automatic production of copper radioisotopes for routine applications 34
Microglial activation in Parkinson Disease and Lewy Body Dementia: PET studies and proteomic analysis 34
Ethanol inhibits the binding of substance P to rat brain cortex NK1 receptors. 34
Asymmetric synthesis and preliminary evaluation of (R)- and (S)-[11C]bisoprolol, a putative beta1-selective adrenoceptor radioligand. 33
Improved synthesis and radiolabeling of [(11)C]MP4A, a suitable ligand for the investigation of the cholinergic system using PET 32
Automation of [11C]acyl chloride syntheses using commercially available 11C-modules 32
Quantitative in vivo imaging of microglia activation using [11C]PK11195 and two reference tissue models 31
11C-Labelling of N-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl]arylcarboxamide derivatives and evaluation as potential radioligands for PET imaging of dopamine D3 receptors 31
Radiosynthesis of the ACE inhibitor [11C]zofenoprilat 30
PET and SPET molecular imaging: focus on serotonin system 29
Basal ganglia and language: phonology modulates dopaminergic release. 29
Cholinergic ligand [11C]MP4A: improved A-acetoxypiperidine precursor synthesis via LC-APCI/MS characterisation and improved radioligand HPLC purification 29
Whole body biodistribution and dosimetry of [11C]-PK11195 a PET tracer of peripheral benzodiazepine receptors. 29
Peripheral benzodiazepine receptors in Creutzfeldt-Jakob disease (CJD): a [11C]PK11195 PET studies 28
Radiochemical synthesis, improved HPLC purification and characterization via LC-APCI/MS of the cholinergic ligand [11C]MP44. 28
Labeling and evaluation of N-[11C]methylated quinoline-2-carboxamides as potential radioligands for visualization of peripheral benzodiazepine receptors. 28
Distribution of sigma receptors in EMT-6 cells: preliminary biological evaluation of PB167 and potential for in-vivo PET. 28
A nonpeptide NK1 receptor agonist showing subpicomolar affinity. 28
Setup and optimization of an automated module for the radiosynthesis of [C-11]CH3I using the 27
Chemical synthesis and characterization of 4-acetoxypiperidine, a [11C]MP4A precursor for the study of the cholinergic system 27
Radiosynthesis of [123I]betaCIT, a selective ligand for the study of the dopaminergic and serotoninergic systems in human brain. 27
PK11195 binding to the peripheral benzodiazepine receptor for monitoring microglia activation in global cell leukodystrophy 26
Gabaergic and serotoninergic system in PWS syndrome: a PET study 26
11C-Radiosynthesis and preliminary human evaluation of the disposition of the ACE inhibitor [11C]zofenoprilat 26
Distribution of [18F]FDG: a challenge for the PET Community 25
Implementations of the commercially available modules of [18F]FDG and Carbon-11 for multiple and large-scale production of PET radiopharmaceuticals 25
Modifications of mu opioid receptors in obesity 25
Longitudinal evaluation of a preclinical model of Huntington disease using molecular imaging techniques and selected radioligands 23
Preparation of [11C]radioligands with high specific radioactivity on a commercial PET tracer synthesizer 23
Value of [11C]choline PET in re-staging prostate cancer: A comparison with [18F]FDG-PET. 22
La radiochimica è solo FDG? Sviluppi/applicazioni di radiofarmaci non FDG. Sviluppo di ligandi marcati con C-11 per lo studio dei sistemi di neurotrasmissione mediante PET. 16
null 1
Totale 2.610
Categoria #
all - tutte 8.969
article - articoli 4.660
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.629


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202423 0 0 0 0 0 0 0 0 1 0 21 1
2024/20251.188 3 6 79 38 427 85 0 54 32 66 221 177
2025/20261.322 58 116 93 199 274 59 200 60 69 88 80 26
2026/202777 74 3 0 0 0 0 0 0 0 0 0 0
Totale 2.610